Page last updated: 2024-11-06

prednisolone and Leiomyomatosis

prednisolone has been researched along with Leiomyomatosis in 1 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Leiomyomatosis: The state of having multiple leiomyomas throughout the body. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Renal biopsy indicated Class V + IV(G)-A lupus nephritis (LN)."1.48Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman. ( Hong, H; Li, X; Ma, Z; Wang, M; Yang, R, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, H1
Yang, R1
Li, X1
Wang, M1
Ma, Z1

Other Studies

1 other study available for prednisolone and Leiomyomatosis

ArticleYear
Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman.
    BMC nephrology, 2018, 04-18, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Female; Humans; I

2018